140 related articles for article (PubMed ID: 21157219)
1. Imaging diagnosis of post-ERCP focal pancreatitis mimicking pancreatic carcinoma by follow-up F-18 FDG PET/CT.
Jeong Yoon S; Lee B; Park CH
Clin Nucl Med; 2011 Jan; 36(1):70-2. PubMed ID: 21157219
[TBL] [Abstract][Full Text] [Related]
2. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
3. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Voth M; Opfermann T; Gottschild D
Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
[TBL] [Abstract][Full Text] [Related]
4. [The role of FDG-PET scan in the diagnosis of pancreatic carcinoma].
Papós M; Takács T; Pávics L; Farkas G; Ambrus E; Szakáll S; Lonovics J; Csernay L; Trón L
Orv Hetil; 2002 May; 143(21 Suppl 3):1283-6. PubMed ID: 12077917
[TBL] [Abstract][Full Text] [Related]
5. The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions.
Papós M; Takács T; Trón L; Farkas G; Ambrus E; Szakáll S; Lonovics J; Csernay L; Pávics L
Clin Nucl Med; 2002 Mar; 27(3):197-201. PubMed ID: 11852308
[TBL] [Abstract][Full Text] [Related]
6. [Endoscopic retrograde cholangio-pancreaticography (ERCP) and computer tomography in the diagnosis of chronic pancreatitis, pseudocysts and carcinoma of the pancreas--a comparison (author's transl)].
Lammer J; Lepuschütz H; Sager WD; Kratochvil P; Brandstätter G; Zalaudek G
Rontgenblatter; 1980 Dec; 33(12):602-11. PubMed ID: 7455535
[TBL] [Abstract][Full Text] [Related]
7. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
8. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Zimny M; Schumpelick V
Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284
[TBL] [Abstract][Full Text] [Related]
9. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.
Matsumoto I; Shirakawa S; Shinzeki M; Asari S; Goto T; Ajiki T; Fukumoto T; Kitajima K; Ku Y
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):712-8. PubMed ID: 23353642
[TBL] [Abstract][Full Text] [Related]
10. [Echography, computerized tomography and retrograde cholangiopancreatography for the diagnosis of focal pathology of the exocrine pancreas].
Pomerri F; Alfieri P; Pescarini L; Pittarello F; Muzzio PC
Radiol Med; 1991; 81(1-2):22-8. PubMed ID: 2006330
[TBL] [Abstract][Full Text] [Related]
11. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
[TBL] [Abstract][Full Text] [Related]
12. The role of fluorodeoxyglucose and positron emission tomography in the evaluation of pancreatic disease.
Rajput A; Stellato TA; Faulhaber PF; Vesselle HJ; Miraldi F
Surgery; 1998 Oct; 124(4):793-7; discussion 797-8. PubMed ID: 9781003
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.
Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH
Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786
[TBL] [Abstract][Full Text] [Related]
14. New sonographic imaging observations in focal pancreatitis.
Lorén I; Lasson A; Fork T; Genell S; Nilsson A; Nilsson P; Nirhov N
Eur Radiol; 1999; 9(5):862-7. PubMed ID: 10369980
[TBL] [Abstract][Full Text] [Related]
15. [CT and ERCP as a combination research method in pancreatic diseases].
Triller J; Kappeler M; Coray T; Halter F
Rofo; 1984 Nov; 141(5):483-90. PubMed ID: 6438710
[TBL] [Abstract][Full Text] [Related]
16. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory pancreatic masses. Problems in differentiating focal pancreatitis from carcinoma.
Neff CC; Simeone JF; Wittenberg J; Mueller PR; Ferrucci JT
Radiology; 1984 Jan; 150(1):35-8. PubMed ID: 6689784
[TBL] [Abstract][Full Text] [Related]
18. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.
Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Lehman GA
Gastrointest Endosc; 2007 Mar; 65(3):385-93. PubMed ID: 17321236
[TBL] [Abstract][Full Text] [Related]
19. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
20. Protocol-based medical management of post-ERCP pancreatitis.
Reddy N; Wilcox CM; Tamhane A; Eloubeidi MA; Varadarajulu S
J Gastroenterol Hepatol; 2008 Mar; 23(3):385-92. PubMed ID: 18318823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
